Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances
- This topic has 0 replies, 1 voice, and was last updated 2 years ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
https://pubmed.ncbi.nlm.nih.gov/35418130/
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.